Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aphria

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

SNDL Inc.

The global pandemic and following lockdowns impacted almost every sector of the economy. And the Canadian cannabis industry was no exception.

Cannabis Analyst: March Earning Season May Not Push Canadian LPs, But There Are Other Catalysts

3 Best Marijuana Stocks so Far This Year: Are They Buys Now?

Tilray, Inc. (TLRY) closed the most recent trading day at $19.77, moving +0.05% from the previous trading session.

Tilray, Inc. (TLRY) Gains But Lags Market: What You Should Know

Even with the global legalization trend, and its upcoming merger, you should consider other cannabis plays over TLRY stock. The post Catalysts Aside, Tilray Stock Remains a Cannabis Name to Avoid appeared first on InvestorPlace.

Catalysts Aside, Tilray Stock Remains a Cannabis Name to Avoid

Current and prospective TLRY stock holders need to get ready for a shareholder meeting that could be an industry game changer. The post Mark Your Calendars for an Upcoming Explosion by Tilray Stock appeared first on InvestorPlace.

Mark Your Calendars for an Upcoming Explosion by Tilray Stock

Transformative changes are afoot, but they might take time to pay off.

Should You Buy Tilray in April?

Tilray Inc's (NASDAQ:TLRY) stock lost a key technical level Wednesday after trading in a bearish pattern for eight weeks. The cannabis company's stock skyrocketed 166% over the course of five trading sessions in February but returned to ground level two weeks later.

Tilray's Stock Just Lost A Key Level, But There May Still Be Hope

British American Tobacco

Frontline

GW Pharmaceuticals

Jazz Pharmaceuticals

Amplify Alternative Harvest ETF

Nordic American Tankers

Star Bulk Carriers

Teekay Tankers

These 2 Stock Market Plays Are Moving Up the Charts in 2021

Aurora Cannabis

Investors appear to be jittery about the prospects for U.S. cannabis reform.

Why Cannabis Stocks Aphria, Aurora Cannabis, Charlotte's Web, and Tilray Slid Today

Tilray and Aphria are set to approve the merger at shareholder meetings next week. The stocks are up substantially since the deal announcement, yet the prospects of the business haven't improved meaningfully.

Tilray: Not A Buy On Aphria Deal Close

With gains ranging from 139% to 175%, these pot stocks were all the buzz.

The 4 Best Marijuana Stocks in the First Quarter

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced both Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis and Co., LLC (“Glass Lewis”) have recommended that holders (the “Shareholders”) of Tilray common shares (the “Shares”) vote FOR the proposals to complete the business combination between Aphria Inc. and Tilray (the “Transaction”). ISS and Glass Lewis are the

Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend Shareholders Vote FOR the Proposed Aphria and Tilray Business Combination

TLRY stock is the original super-spike mega-squeeze ticker. It had its fun in 2018 but now it's a legitimate investment thesis through 2021.

Tilray Stock Action Is Wild But Calmer Days Are Ahead

The Tilray-Aphria merger should make a profitable cannabis company. TLRY might be profitable after synergies, but investors may be able to buy TLRY stock cheaper.

Tilray Should Come Out of its Aphria Merger Stronger

Tilray Inc. (NASDAQ:TLRY) stock is down over 66% following it's run to $67 on Feb. 25, when the company was targeted by r/WallstreetBets traders. The meme stock has been trading in a consolidating range for the last few weeks, and options traders may be thinking Tilray stock is gearing up for another run.

Options Traders Think Tilray Stock Can Rebound Following New York Legalization

There are many factors – mostly related to politics – that favor TLRY stock. But the black market continues to pose big challenges.

The Black Market Imposes a Dark Cloud on Tilray

GrowGeneration Corp

As Congress pushes for the federal legalization of pot, and New York joins other legalized states, cannabis stocks are soaring. The post Cannabis Stocks: Why TLRY, APHA, OGI, GRWG, SNDL Stocks Are Getting High appeared first on InvestorPlace.

Cannabis Stocks: Why TLRY, APHA, OGI, GRWG, SNDL Stocks Are Getting High

Canopy Growth

Cronos Group

After years of wrangling, both houses of the New York state legislature on Tuesday passed a bill that legalizes recreational marijuana, and it wasn't even really close.

Pot Stocks Jump as Marijuana One Signature Away from Being Legal in New York

Cannabis stocks have been the talk lately as recreational legalization advances in New York. Three stocks that look to be nearing support are Tilray Inc. (NASDAQ:TLRY), Canopy Growth Corp. (NASDAQ:CGC) and Aurora Cannabis Inc. (NYSE:ACB).

3 Cannabis Stocks Looking For Support

Tilray and Aphria shareholders vote on their merger in mid-April. If you believe it will be yes vote, do you buy TLRY stock or APHA?

Buy Aphria if You Believe in Its Tie-up With Tilray

TLRY stock may become a key global cannabis player in the future but its valuation is too high to get excited just yet. The post Tilray Has a Promising Future, But Valuation Now Is Too High appeared first on InvestorPlace.

Tilray Has a Promising Future, But Valuation Now Is Too High

The legalization wave continues to run on basically a best-case trajectory in the US, with New Jersey and New York making moves to legalize over recent weeks. The size of the US market continues to grow rapidly in legal terms, with Forbes recently putting out a piece suggesting the $24 billion threshold is attainable this […]

In Search of the Next Hot Pot Stock (OTC US: GRWG) (NASDAQ: TLRY) (OTC US: SGMD) (NASDAQ: APHA)

The Empire State will become the 16th to sanction adult-use cannabis.

New York State Lawmakers Reach a Deal to Legalize Recreational Marijuana

New York state lawmakers said today legislation to legalize recreational marijuana could be passed as soon as next week, but cannabis stocks appeared largely indifferent to the news. The post Cannabis Stocks: The Latest News Hitting APHA, TLRY, SNDL, GRWG Stocks Today appeared first on InvestorPlace.

Cannabis Stocks: The Latest News Hitting APHA, TLRY, SNDL, GRWG Stocks Today

Altria

Molson Coors Brewing

Several U.S. states continue to legalize recreational use of marijuana, with New York being the latest to consider taking action on the issue. Several states in the southern U.S., including Alabama and Georgia, are aggressively moving to legalize both recreational and medical marijuana.

7 Marijuana Stocks to Buy as the South Goes Green

News for Tilray Brands Stock (TLRY)